title: Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.
abstract: Nucleic acids carry the building plans of living systems. As such, they can be exploited to make cells produce a desired protein, or to shut down the expression of endogenous genes or even to repair defective genes. Hence, nucleic acids are unique substances for research and therapy. To exploit their potential, they need to be delivered into cells which can be a challenging task in many respects. During the last decade, nanomagnetic methods for delivering and targeting nucleic acids have been developed, methods which are often referred to as magnetofection. In this review we summarize the progress and achievements in this field of research. We discuss magnetic formulations of vectors for nucleic acid delivery and their characterization, mechanisms of magnetofection, and the application of magnetofection in viral and nonviral nucleic acid delivery in cell culture and in animal models. We summarize results that have been obtained with using magnetofection in basic research and in preclinical animal models. Finally, we describe some of our recent work and end with some conclusions and perspectives.
authors: Institute of Experimental Oncology and Therapy Research, Technische Universität München, Munich, Germany. plank@lrz.tum.de
authors: Christian
authors: C
authors: Plank
authors: Olivier
authors: O
authors: Zelphati
authors: Olga
authors: O
authors: Mykhaylyk
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D000818:Animals; D004337:Drug Carriers / Q000737:chemistry*; D005822:Genetic Vectors; D006801:Humans; D016086:Lentivirus / Q000235:genetics; D008280:Magnetics; D058185:Magnetite Nanoparticles / Q000737:chemistry*; D009696:Nucleic Acids / Q000008:administration & dosage* / Q000235:genetics; D055672:Static Electricity; D013499:Surface Properties; D014162:Transfection / Q000379:methods / Q000639:trends
chemical_list: D004337:Drug Carriers; D058185:Magnetite Nanoparticles; D009696:Nucleic Acids